查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466746

細胞培養市場：按產品、應用和最終用途 - 2024-2030 年全球預測

Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年細胞培養市場規模為262.9億美元，預計2024年將達301.2億美元，2030年將達682億美元，複合年成長率為14.58%。

細胞培養是一種實驗技術，用於在不同於自然環境（例如活生物體）的受控環境中培養細胞。這種方法使研究人員和科學家能夠詳細研究細胞行為、生物學和生理學。細胞培養應用於醫學研究、製藥、生物技術等各個領域，甚至製造業的某些部分。細胞培養技術的應用範圍廣泛，包括藥物開發、疫苗生產、癌症研究、基因工程和生技藥品的生產。它在新藥開發、毒性測試、疾病機制闡明等方面發揮重要作用。在製藥和生物技術產業，細胞培養在生物製藥和抗體的生產中發揮著至關重要的作用。此外，細胞培養在再生醫學和組織工程中的作用凸顯了其在製定慢性疾病和病理治療策略中的重要性。細胞培養市場的成長是由3D細胞培養和自動化細胞培養系統等細胞培養技術的創新、對治療性單株抗體的需求增加、對生物技術和藥物研究活動的投資增加以及全球慢性病需求的增加所推動的。然而，細胞培養市場面臨某些限制，例如高成本、倫理問題、培養維護的複雜性以及與先進細胞培養技術相關的污染風險。同時，3D細胞培養技術的進步、細胞培養在個人化醫療中的應用以根據個體的基因譜客製化治療方案、細胞培養在再生醫學中的應用研究以及細胞培養在永續食品生產中的應用正在快速成長。

主要市場統計
基準年[2023] 262.9億美元
預測年份 [2024] 301.2億美元
預測年份 [2030] 682億美元
複合年成長率（%） 14.58%

產品：細胞培養將越來越青睞具有可靠性、可擴展性和先進功能的設備。

消耗品是指經常使用並需要更換的產品。它在確保細胞培養操作的品質和完整性方面發揮著重要作用。反應器配件是反應器中使用的組件，支援生物活性環境的設備，以提高其效率和產量。培養基是細胞生長的營養豐富的溶液，分為經典培養基和無鹽無血清培養基。試劑是添加到細胞培養物中以產生所需效果的物質或化合物，例如用於防止細菌/真菌污染或防止細胞黏附到培養容器的抗生素/抗真菌劑，其中包括輔助的黏附/基質因子。細胞工廠系統/細胞堆、燒瓶和多孔孔盤是培養細胞的容器。它們有各種尺寸和型態，並經過客製化以滿足不同類型細胞培養的需求。傳統或一次性反應器對於研究和生產目的的大量培養細胞反應器。特別是，一次性反應器因其便利性和降低污染風險而受到關注。低溫保存系統、冰箱和冷凍庫對於將細胞和生物樣本保存在適當的溫度以確保長期活力至關重要。高壓釜、生物安全櫃和二氧化碳培養箱對於維持無菌環境和確保細胞培養的安全性和完整性至關重要。耗材是一項持續支出，長遠來看會對細胞培養的整體營運成本產生重大影響。另一方面，設備需要較高的初始投資，但使用壽命較長，長期來看可能會降低成本。雖然耗材選擇通常側重於品質、批次一致性和道德考慮，但設備偏好傾向於可靠性、可擴展性和增強培養條件和監控的高級功能。

最終用途：透過擴大細胞培養在醫院和診斷實驗室的使用來提高效率和診斷準確性

在醫院和診斷實驗室中，細胞培養主要用於診斷目的，例如癌症診斷、病毒檢測和藥物篩檢。隨著對準確性、可靠性和速度的關注，人們對自動化細胞培養系統越來越感興趣，以簡化工作流程並減少人為錯誤。製藥和生物技術公司在考慮細胞培養在藥物開發、生技藥品製造和疫苗製造中的應用時，優先考慮可擴展性、一致性和法規遵循。重點是高產、經濟高效的培養系統，可以縮短新療法的上市時間。研究和學術機構正在轉向彈性、多樣化和特定的細胞培養產品來支持廣泛的研究領域，包括幹細胞研究、癌症研究和再生醫學。這裡的需求是專業的培養基配方、先進的培養系統（如 3D 培養）以及對尖端研究活動的支援。比較這三個細分市場表明，每個細分市場都有由其最終目標決定的自己的需求。醫院和診斷實驗室優先考慮效率和診斷準確性，製藥和生物技術公司優先考慮治療製造的可擴展性和合規性，研究機構和學術機構尋求廣泛的研究應用的多功能性。

區域洞察

美國作為生物技術研發中心，是細胞培養產品的重要市場。該地區的需求是由強大的研究基礎設施、對生命科學的大量投資以及大型製藥和生物技術公司的存在所推動的。對個人化醫療和再生療法的關注將進一步提振市場。由於公共和私營部門不斷增加的研發投資，南美細胞培養市場正處於成長階段。由於生物製藥行業的擴張、生命科學投資的增加以及政府對生物技術新興企業的支持，亞太地區對細胞培養的需求正在激增。在政府旨在促進再生醫學、生技藥品製造和幹細胞研究的舉措的支持下，中國市場正在蓬勃發展。日本先進的醫療系統和對品質的重視使其成為先進細胞培養系統的重要市場。印度細胞培養市場在蓬勃發展的生物技術產業、不斷增加的生物醫學研究以及疫苗和生技藥品生產的推動下不斷成長。歐盟因其強大的研究能力、法律規範以及在生物技術和製藥領域的大量投資而脫穎而出。癌症研究、再生醫學和疫苗製造等活躍的研究領域正在推動對細胞培養產品的需求。成員國之間的合作研究措施進一步加強了市場。儘管中東和非洲地區是一個新興地區，但由於醫療投資的增加以及生命科學領域研發活動的逐漸轉向，細胞培養顯示出成長潛力。

FPNV定位矩陣

FPNV定位矩陣對於評估細胞培養市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對細胞培養市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析也為此細分市場的競爭特徵提供了寶貴的見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動以及突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.細胞培養市場的市場規模與預測是多少？

2.在細胞培養市場預測期內需要考慮投資的產品、細分市場、應用和細分市場有哪些？

3. 細胞培養市場的技術趨勢和法規結構是什麼？

4.細胞培養市場主要廠商的市場佔有率為何？

5.進入細胞培養市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對治療用途單株抗體的需求增加
      • 增加對生物技術和藥物研究活動的投資
      • 世界各地慢性病的發生率正在上升
    • 抑制因素
      • 與先進的細胞培養技術和無菌條件的維持相關的高成本
    • 機會
      • 擴大細胞培養在個人化醫療的應用，根據個人的遺傳特徵客製化治療方案
      • 利用細胞培養實現永續食品生產的培養肉需求不斷成長
    • 任務
      • 培養物維護的複雜性與污染風險
  • 市場區隔分析
    • 產品：可靠、可擴展且功能強大的細胞培養設備正在成為優先考慮的因素
    • 最終用途：擴大細胞培養在醫院和診斷實驗室的使用，以提高效率和診斷準確性
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章細胞培養市場：依產品

  • 介紹
  • 消耗品
  • 裝置

第7章細胞培養市場：依應用分類

  • 介紹
  • 生物製藥製造
  • 診斷
  • 藥物篩檢與開發
  • 幹細胞研究
  • 組織工程與再生醫學

第8章細胞培養市場：依最終用途

  • 介紹
  • 醫院和診斷實驗室
  • 製藥和生物技術公司
  • 研究/學術機構

第9章美洲細胞培養市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太細胞培養市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲細胞培養市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-034230D3E63B

[186 Pages Report] The Cell Culture Market size was estimated at USD 26.29 billion in 2023 and expected to reach USD 30.12 billion in 2024, at a CAGR 14.58% to reach USD 68.20 billion by 2030.

Cell culture is a laboratory method used to grow cells in a controlled environment outside of their natural setting, such as a living organism. This method allows researchers and scientists to study the behavior, biology, and physiology of cells in detail. Cell culture is utilized in various fields, including medical research, pharmaceuticals, biotechnology, and even some aspects of manufacturing. The applications of cell culture technology are vast and varied, encompassing drug development, vaccine production, cancer research, genetic engineering, and the manufacture of biologics, among others. It plays a crucial role in developing new medicines, testing for toxicity, and understanding disease mechanisms. In the pharmaceutical and biotechnology industries, cell culture is pivotal in producing biopharmaceuticals and antibodies. Moreover, its role in regenerative medicine and tissue engineering underlines its significance in developing therapeutic strategies for chronic diseases and conditions. Several factors contribute positively to the growth of the cell culture market, including innovations in cell culture technologies, such as 3D cell culture and automated cell culture systems, growing demand for monoclonal antibodies for therapeutic applications, higher investment in biotechnology and pharmaceutical research activities, and rising incidence of chronic diseases worldwide. However, the cell culture market faces certain limitations, such as the high costs associated with advanced cell culture technologies, ethical issues, the complexity of maintaining cultures, and the risk of contamination. On the other hand, advancements in 3D cell culture technology, the use of cell culture in personalized medicine for tailoring treatments to individual genetic profiles, research into cell culture applications in regenerative medicine, and the burgeoning field of cultured meat, using cell culture for sustainable food production opens new avenues for the development of cell culture market.

KEY MARKET STATISTICS
Base Year [2023] USD 26.29 billion
Estimated Year [2024] USD 30.12 billion
Forecast Year [2030] USD 68.20 billion
CAGR (%) 14.58%

Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features

Consumables are products that are regularly used up and need replacement. They play a critical role in ensuring the quality and integrity of cell culture work. Bioreactor accessories are components used with bioreactors, devices that support a biologically active environment, to improve their efficiency and output. Media is the nutrient-rich solution that cells grow in, and It can be divided into classical media & salts and serum-free media. Reagents are substances or compounds added to the cell culture to bring about a desired effect, such as antibiotics/antimycotics used to prevent bacterial/fungal contamination; attachment & matrix factors to help cells attach to the culture vessel; and balanced salt solutions to maintain the osmotic balance and pH. Cell factory systems/cell stacks, flasks, and multiwell plates are containers where cells are grown. They come in various sizes and shapes, tailored to different types of cell culture needs. Conventional bioreactors and single-use bioreactor devices are essential for growing cells in large quantities for research or production purposes. Single-use bioreactors are particularly noted for their convenience and reduced contamination risk. Cryostorage systems, refrigerators & freezers are vital for preserving cells and biological materials at appropriate temperatures, ensuring they remain viable over time. Autoclaves, biosafety cabinets, and carbon dioxide incubators are essential to maintain a sterile environment, ensuring the safety and integrity of cell cultures. Consumables are a continuous expense and can significantly impact the overall cost of cell culture operations in the long term. In contrast, equipment represents a higher initial investment but offers a longer service life, potentially reducing costs over time. Selection of consumables often focuses on quality, batch consistency, and ethical considerations, whereas equipment preferences lean towards reliability, scalability, and advanced features that enhance culture conditions and monitoring.

End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy

In hospitals and diagnostic laboratories, cell culture is primarily employed for diagnostic purposes, including cancer diagnosis, virology studies, and drug screening. The emphasis is on accuracy, reliability, and speed, with a growing interest in automated cell culture systems to streamline workflow and reduce human error. Pharmaceutical & biotechnology companies prioritize scalability, consistency, and regulatory compliance, given the cell culture applications in drug development, biologics production, and vaccine manufacturing. The focus is on high-yield, cost-effective culture systems that can expedite the time-to-market for new therapeutics. Research and academic institutes focus on flexibility, variety, and specificity in cell culture products to support a broad range of research areas, including stem cell research, cancer research, and regenerative medicine. The demand here is for specialized media formulations, advanced culture systems such as 3D cultures, and support for cutting-edge research endeavors. Upon comparing the three segments, it becomes evident that each has unique requirements shaped by their end goals. Hospitals and diagnostic laboratories prioritize efficiency and diagnostic accuracy, pharmaceutical and biotechnology companies focus on scalability and compliance for therapeutic production, and research and academic institutes demand versatility for a wide swath of research applications.

Regional Insights

The United States, being a hub for biotechnological research and development, stands out as a significant market for cell culture products. The demand here is driven by a robust research infrastructure, substantial investments in life sciences, and the existence of major pharmaceutical and biotechnology companies. The focus on personalized medicine and regenerative therapies further boosts the market. The South American cell culture market is in a growth phase, fueled by increasing investment in research and development by both public and private sectors. The Asia Pacific region is experiencing rapid growth in cell culture demand due to its expanding biopharmaceutical sector, increasing investments in life sciences, and government support for biotechnology startups. China's market is booming, supported by government initiatives aimed at advancing regenerative medicine, biologics production, and stem cell research. Japan's sophisticated healthcare system and strong emphasis on quality are significant markets for advanced cell culture systems. India's cell culture market is growing, fueled by its burgeoning biotech industry, increased biomedical research, and the production of vaccines and biologics. The EU stands out for its strong research capabilities, regulatory frameworks, and substantial investments in the biotechnology and pharmaceutical sectors. The demand for cell culture products is driven by active research areas, including cancer research, regenerative medicine, and vaccine production. Collaborative research initiatives across member states further enhance the market. The Middle East and Africa region, although emerging, shows potential for growth in cell culture due to increasing healthcare investment and a gradual shift towards research and developmental activities in the life sciences sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Bioreactor Accessories
      • Sera, Media, and Reagents
        • Media Classical Media & Salts

Serum-Free Media

Specialty Media

Stem Cell Culture Media

        • Reagents Antibiotics/Antimycotics

Attachment & Matrix Factors

Balanced Salt Solutions

Buffers & Chemicals

Cell Dissociation Reagents

Contamination Detection Kits

Cryoprotective Reagents

        • Sera Adult Bovine Sera

Fetal Bovine Sera

      • Vessels
        • Cell Factory Systems/Cell Stacks
        • Flasks
        • Multiwell Plates
        • Petri Dishes
        • Roller/Roux Bottles
    • Equipment
      • Bioreactors
        • Conventional Bioreactors
        • Single-Use Bioreactors
      • Storage Equipment
        • Cryostorage System
        • Refrigerators & Freezers
      • Supporting Equipment
        • Autoclaves
        • Biosafety Cabinets
        • Carbon Dioxide Incubators
        • Cell Counters
        • Centrifuges
        • Filtration System
        • Microscopes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibody Production
      • Vaccine Production
    • Diagnostics
    • Drug Screening & Development
    • Stem Cell Research
    • Tissue Engineering & Regenerative Medicine
  • End-Use
    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Culture Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Culture Market?

3. What are the technology trends and regulatory frameworks in the Cell Culture Market?

4. What is the market share of the leading vendors in the Cell Culture Market?

5. Which modes and strategic moves are suitable for entering the Cell Culture Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
      • 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
      • 5.1.1.3. Rising incidence of chronic diseases worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
      • 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
    • 5.1.4. Challenges
      • 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
    • 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment

7. Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Production
  • 7.3. Diagnostics
  • 7.4. Drug Screening & Development
  • 7.5. Stem Cell Research
  • 7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostic Laboratories
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. Americas Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
    • 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
    • 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL CULTURE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 106. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 107. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 108. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 109. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 112. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 113. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 114. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 115. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 116. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 117. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 118. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 119. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 120. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 121. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 122. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 123. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 124. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 125. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 130. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 131. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 132. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 133. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 134. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 135. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 138. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 139. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 140. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 141. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 142. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 143. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 144. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 145. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 146. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 147. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 148. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 149. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 150. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 151. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 152. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 153. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 154. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 155. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 156. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 157. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 160. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 161. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 168. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 169. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 170. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 171. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 172. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 173. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 174. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 175. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 176. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 177. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 178. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 179. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 180. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 181. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 182. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 183. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 184. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 185. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 186. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 187. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 190. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 191. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 196. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 197. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 198. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 199. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 200. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 201. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 202. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 203. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 204. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 205. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 206. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 207. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 208. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 209. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 210. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 211. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 214. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 215. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 218. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 219. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 220. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 221. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 224. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 225. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 226. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 227. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 228. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 229. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 230. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 231. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 232. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 233. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 234. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 235. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 236. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 237. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 238. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 239. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 240. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 241. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 242. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 243. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 246. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 247. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 252. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 253. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 254. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 255. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 256. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 257. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 258. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 259. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 260. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 261. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 262. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 263. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 264. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 265. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 266. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 267. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 268. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 269. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 270. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 271. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 274. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 275. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 297. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 298. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 299. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 302. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 303. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 304. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 305. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 306. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 337. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 340. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 341. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 342. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 343. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 344. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 345. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 346. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 347. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 348. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 349. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 350. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 351. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 352. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 353. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 354. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 355. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 356. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 357. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 358. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 359. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 360. AUSTRALIA C